Head and Neck Cancer Drugs size is expected to be valued at USD 1.41 billion by 2022 : Grand View Research, Inc.,

The global head and neck cancer drugs market size is expected to be valued at USD 1.41 billion by 2022, as per a new report by Grand View Research, Inc., registering a CAGR of 9.4% during the forecast period. The market is expected to be collectively driven by development of innovative and cost-effective treatments, numerous side effects related to radiation therapy and chemotherapy, increased healthcare expenditure, and better government initiatives.

As most patients suffering from head and neck cancer are diagnosed at an advanced stage, their management is often done with a multidisciplinary approach involving surgery, radiation therapy, chemotherapy, and immunotherapy in the head and neck cancer therapeutics market. Major challenges faced by this patient population are morbidity issues and poor quality of life owing to the incapacitating effects of standard of care treatment paradigms. Anemia, diarrhea, nausea, vomiting, joint pain, and osteoporosis are some of the main side effects resulting from head and neck cancer treatments.

Based on recent clinical results, immunotherapies have gained traction as a precision medicine initiative for the management of head and neck cancer. Increased immunity and immune modulation research in cancer offers new vulnerabilities that may be pharmacologically exploitable. Immunotherapy drugs such as PD inhibitors, Opdivo, and Keytruda have shown superior safety and efficacy profile in treatment of head and neck cancer. Expansion of immunotherapies will continue moving toward rational combinations with other first line or adjuvant therapies for effective treatment of metastatic or recurrent head and neck cancer. EGFR and microtubule inhibitor therapeutic classes are witnessing a fundamental shift from biologics to biosimilars.

Full research report on keyword analysis:
https://www.grandviewresearch.com/industry-analysis/head-neck-cancer-drugs-therapeutics-market

Further key findings from the report suggest:

·         Market growth will be driven by rising number of patients, increasing adoption of immunotherapeutic drugs, and launch of new drug delivery approaches to improve overall survival rates

·         Among EU5, Germany captured the top position in the global head and neck cancer therapeutics market, whereas by 2022, Spain is expected to lead the market. U.S. is expected to witness the fastest growth over the forecast period

·         Immune checkpoint inhibitors such as Opdivo and Keytruda are gaining traction and will continue to do so through forecast period, capturing more than 60.0% of the market in 2022

·         PD inhibitors will capture market share from microtubule inhibitors and EGFR inhibitors but will help expand overall franchise revenue

·         Newer immunotherapies directed against PD-1 ligands and PD-L1 proteins have shown to be more effective with superior safety profile

·         Late stage pipeline products include checkpoint inhibitors such as Imfinzi and Bavencio

·         Key players operating in this industry include Bristol-Myers Squibb, Merck, Eli Lilly, and Sanofi.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global head and neck cancer drugs market based on therapeutic class and region:

Head and Neck Cancer Drugs Therapeutic Class Outlook (Revenue, USD Million, 2016 - 2022)

·         PD Inhibitors

·         EGFR Inhibitors

·         Microtubule Inhibitors

Head and Neck Cancer Drugs Regional Outlook (Revenue, USD Million, 2016 - 2022)

·         U.S.

·         U.K.

·         France

·         Germany

·         Italy

·         Spain

·         Japan

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-head-neck-cancer-drugs-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Connected Enterprise Market size is expected to reach USD 1.94 trillion by 2025 : Grand View Research, Inc.

The global connected enterprise market size is expected to reach USD 1.94 trillion by 2025, according to a new report by Grand View Research, Inc. The increasing need for automation and proliferation of connected devices is providing new growth avenues for the connected enterprise market.

Enterprises are moving toward digital technologies to transform their business operations, improve customer experiences and rapidly respond to emerging threats and opportunities. Industry collaborations with connected technology are gaining prominence for improving agility, productivity, and business process management. Although the Internet-of-Things (IoT) and connected technologies are becoming adept, several organizations have not included their collaboration with smart technologies in business strategies.

The implementation of intelligent networks has improved optimization of assets including equipment reliability, and energy usage and has expanded the capacity of existing assets. Enterprises are integrating people, tools, processes, and platforms comprising infrastructure and applications to disrupt the business productivity with next-generation solutions.

Moreover, organizations are looking for innovative ways to differentiate themselves from their competitors and overcome threats from new entrants. Connected solutions are increasingly adopted for generating new revenue streams and improving profit margins. These solutions help enterprises in increasing their operational efficiency by enabling real-time monitoring of assets. However, fragmented technology standards and growing security concerns are expected to deter the industry growth.

Full research report on connected enterprise market analysis: http://www.grandviewresearch.com/industry-analysis/connected-enterprise-market

Further key findings from the report suggest:

·         Customer experience management is expected to be the fastest-growing segment owing to its transition from being transactional to more interactive and informative solution

·         The managed services segment is expected to grow at a CAGR of over 35% from 2016 to 2025. due to the increasing need for outsourcing IoT-related capabilities

·         The device management platform is anticipated to account for over 25% revenue share by 2025; the need to drive connected products assessment, reduce operational costs, and improve service quality is propelling the demand for a device management platform

·         The healthcare sector is expected to reach a valuation of over USD 150 billion by 2025 on account of its transition from providing provider-centric to patient-centric solutions

·         The Asia Pacific region is expected to be the fastest-growing regional market as the enterprises in the region are deploying connected infrastructure in new areas to improve their revenues.

·         The key industry players include IBM Corporation, Rockwell Automation, Inc., IBM Corporation, Honeywell International, Inc., and PTC Inc.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the connected enterprise market based on component, solution, services, platform, application, and region:

Connected Enterprise Component Outlook (Revenue, USD Billion, 2014 - 2025)

·         Solution

·         Service

·         Platform

Connected Enterprise Solution Outlook (Revenue, USD Billion, 2014 - 2025)

·         Manufacturing execution system

·         Customer experience management

·         Business analytics

·         Application value management

·         Remote monitoring

Connected Enterprise Service Outlook (Revenue, USD Billion, 2014 - 2025)

·         Professional services

·         Managed services

Connected Enterprise Platform Outlook (Revenue, USD Billion, 2014 - 2025)

·         Connectivity management

·         Application enablement and development

·         Device management

Connected Enterprise Application Outlook (Revenue, USD Billion, 2014 - 2025)

·         Manufacturing

·         BFSI

·         IT & telecom

·         Retail

·         Healthcare

·         Food & beverage

·         Others

Connected Enterprise Regional Outlook (Revenue, USD Billion, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    China

o    India

o    Japan

·         Latin America

o    Brazil

o    Mexico

·         Middle East and Africa

Access press release by Grand View Research:
https://www.grandviewresearch.com/press-release/global-connected-enterprise-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Gamma Oryzanol Market expected to reach USD 2.06 billion by 2022 : Grand View Research, Inc.

The global gamma oryzanol market is expected to reach USD 2.06 billion by 2022, according to a new report by Grand View Research, Inc. Increasing consumer awareness towards a healthy lifestyle is expected to drive product demand over the next seven years.

Improper diet intake coupled with rising health treatment expenditure has urged consumers to switch to alternatives, such as dietary supplements, that offers a balanced diet. Gamma oryzanol plays a significant role in boosting good cholesterol and minimize adverse impacts of unhealthy diet intake.

Rapid urbanization coupled with increasing participation in health clubs and fitness activities are expected to play a vital role in industry growth over the forecast period. High product price along with the lack of consumer awareness are expected to remain major factors hindering market growth.

Technological innovation in the industry includes research initiatives to enhance yield rate from rice bran oil that is anticipated to reduce production costs and enable market players to attain economies of scale. Ongoing technological innovations along with increasing R&D spending is expected to provide significant opportunities for gamma oryzanol manufacturers over the forecast period.

Sports supplement emerged as the principal application segment and accounted for over 40% of total revenue in 2014. The segment is anticipated to witness moderate growth rate owing to high requirement of gamma oryzanol as an essential supplement for sports nutrition.

Full research report on gamma oryzanol market analysis:
http://www.grandviewresearch.com/industry-analysis/gamma-oryzanol-market

Further key findings from the report suggest:

·         The global gamma oryzanol market demand was 11,520.0 tons in 2014 and is expected to reach 18,597.8 tons by 2022, growing at an estimated CAGR of 6.2% from 2015 to 2022

·         Gamma oryzanol demand in cosmetic applications is anticipated to witness the highest growth over the forecast period. The segment is estimated to grow at a CAGR of 6.9% in terms of demand from 2015 to 2022.

·         The product demand in animal feed in the U.S. was over 710 tons in 2014. High requirement of the micronutrient in horses and dogs to enhance muscle development may be attributed to significant development in the segment.

·         Europe was the leading regional market and accounted for 30% of total consumption in 2014. The increasing acceptance of sports supplements as an essential form of nutrition in the UK, Italy, and Germany is expected to remain a key factor driving regional market.

·         Asia Pacific is estimated to witness the highest growth of 7.1%over the forecast period. Abundant raw material availability coupled with significant developments in cosmetics and animal feed sectors particularly in Japan, China, Vietnam, and India are anticipated to steer industry growth.

·         Key players operating in the global gamma oryzanol market include Oryza Oil & Fat Chemical Co., Ltd., Jining Ankang Pharmaceutical, Honson Pharmatech Group, KangCare Bioindustry, Lamotte Oils, Tsuno Rice, Xi’an Realin Biotechnology, Shanghai Freemen LLC, Chromadex Inc., and Sunrise Nutrachem Group Co. Ltd.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/specialty-and-fine-chemicals

Grand View Research has segmented the gamma oryzanol market on the basis of application and region:

Global Gamma Oryzanol Application Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2022)

·         Sports supplements

·         Cosmetics

·         Pharmaceuticals

·         Animal feed

Global Gamma Oryzanol Regional Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2022)

·         North America

o    U.S.

·         Europe

o    France

o    Germany

o    UK

·         Asia Pacific 

o    China

o    India

·         Central & South America

·         Middle East & Africa

Access press release by Grand View Research:
https://www.grandviewresearch.com/press-release/global-gamma-oryzanol-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Atherectomy Devices Market is expected to reach USD 894.69 million by 2025 : Grand View Research, Inc.

The global atherectomy devices market is expected to reach USD 894.69 million by 2025, based on a new report by Grand View Research, Inc. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease.

New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2016, Cardiovascular Systems Inc. submitted an application for approval to Pharmaceuticals and Medical Devices Agency (PMDA), Japan’s regulatory agency for pharmaceuticals and medical devices. The company intends to launch Diamondback 360 Coronary OAS Micro Crown in the region and is looking for potential distributors. This would be the company’s first international market entry and the approval procedure is yet to be completed.

Full research report on atherectomy devices market analysis:  
http://www.grandviewresearch.com/industry-analysis/atherectomy-device-market

Further Key Findings from the Study Suggest:

·         Directional atherectomy devices was the largest segment in terms of revenue in the year 2016. This can be attributed to their capability of collecting the shaved plaque in a collecting space, which reduces the risk of barotrauma, dissection, and neointimal hyperplasia.

·         Laser atherectomy devices is expected to the fastest growing segment over the next 8 years. Laser technique is perceived as to have more precision in plaque removal and cause fewer complications. It is also believed to result in lesser incidence of restenosis.

·         Geographically, North America held the largest market share in 2015 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.

·         Asia Pacific is anticipated to observe the fastest growth over the coming years. Improving economic conditions leading to increasing prevalence of lifestyle diseases, especially cardiovascular and peripheral, is the key reason for this growth.

·         Some of the key industry contributors are Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic (Covidien), Spectranetics, VOLCANO CORPORATION, Avinger Inc., Bayer AG, Straub Medical AG, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), and Terumo IS.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the atherectomy devices market by type and region:

Atherectomy Devices Type Outlook (Market Revenue in USD Million, 2014 - 2025)

·         Directional atherectomy devices

·         Rotational atherectomy devices

·         Orbital atherectomy devices

·         Laser atherectomy devices

Atherectomy Devices Regional Outlook (Market Revenue in USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    China

o    Japan

·         Latin America

o    Brazil

·         Middle East and Africa

o    South Africa

Access press release by Grand View Research:
https://www.grandviewresearch.com/press-release/global-atherectomy-device-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com